Literature DB >> 9472656

Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)

J Vingerhoets1, M Dohlsten, G Penne, R Colebunders, D Sansom, E Bosmans, L Kestens, G Vanham.   

Abstract

T cell receptor (TCR) triggering via superantigens induces decreased proliferative responses and increased apoptosis in T cells from HIV-infected patients compared with controls. Our aim was to delineate the role of intrinsic T cell defects, of APC dysfunction and of cytokines and costimulatory signal dysregulation in the deficient responses of CD4+ and CD8+ T cells from HIV+ subjects to the superantigen Staphylococcus enterotoxin A (SEA). Proliferation and IL-2R alpha up-regulation on SEA-stimulated CD4+ and CD8+ T cells in whole blood were reduced in HIV+ subjects with CD4 counts < 500, compared with controls. Neither addition of IL-2, IL-12 or phorbol myristate acetate (PMA) nor neutralization of endogenous IL-10, tumour necrosis factor-alpha (TNF-alpha), TNF-beta or transforming growth factor-beta (TGF-beta) could restore the decreased activation by SEA. Possible intrinsic T cell defects were studied by presenting SEA on HLA-DR-transfected Chinese hamster ovary (CHO) cells, co-expressing LFA3 and/or CD80, to purified T cells. In this system CD8+ T cells from most HIV+ patients were hyporesponsive with regard to IL-2 production, IL-2R alpha up-regulation and proliferation, whereas clearly reduced responses were only shown in CD4+ T cells from AIDS patients. Similarly, apoptosis was increased in CD8+ T cells from all patients, but only in CD4+ T cells from AIDS patients. During HIV infection, the responses to TCR triggering through SEA are deficient in both T cell subsets. The intrinsic defect appears earlier during disease progression in purified CD8+ T than in CD4+ T cells, it occurs in conjunction with both CD2 and CD28 costimulation, and it is correlated with increased levels of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472656      PMCID: PMC1904857          DOI: 10.1046/j.1365-2249.1998.00465.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules.

Authors:  E Parra; A G Wingren; G Hedlund; H O Sjögren; T Kalland; D Sansom; M Dohlsten
Journal:  Scand J Immunol       Date:  1993-12       Impact factor: 3.487

Review 2.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

3.  Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

Authors:  N J Borthwick; M Bofill; W M Gombert; A N Akbar; E Medina; K Sagawa; M C Lipman; M A Johnson; G Janossy
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

4.  Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

Authors:  G Pantaleo; J F Demarest; H Soudeyns; C Graziosi; F Denis; J W Adelsberger; P Borrow; M S Saag; G M Shaw; R P Sekaly
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

Review 5.  T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

Authors:  L Meyaard; H Schuitemaker; F Miedema
Journal:  Immunol Today       Date:  1993-04

6.  Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients.

Authors:  J J Saukkonen; H Kornfeld; J S Berman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-11

7.  Proliferative response of CD4+ and CD8+ T cell subsets from Hispanics with HIV+ and AIDS: the superantigen hypothesis.

Authors:  E H Eylar; C Rivera-Quiñones; H I Laroche; Y Yamamura
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-02

8.  Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations.

Authors:  J E Brinchmann; J H Dobloug; B H Heger; L L Haaheim; M Sannes; T Egeland
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

9.  Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.

Authors:  L Kestens; G Vanham; C Vereecken; M Vandenbruaene; G Vercauteren; R L Colebunders; P L Gigase
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.

Authors:  E Parra; A G Wingren; G Hedlund; M Björklund; H O Sjögren; T Kalland; D Sansom; M Dohlsten
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

View more
  8 in total

Review 1.  Immunofluorescence analysis of T-cell responses in health and disease.

Authors:  H T Maecker; V C Maino; L J Picker
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 2.  Immune activation in the context of HIV infection.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; Z Grossman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination.

Authors:  D Elias; D Wolday; H Akuffo; B Petros; U Bronner; S Britton
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.

Authors:  K Steiner; I Waase; T Rau; M Dietrich; B Fleischer; B M Bröker
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.

Authors:  K Steiner; F Moosig; E Csernok; K Selleng; W L Gross; B Fleischer; B M Bröker
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 7.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Blockade of LAG-3 Immune Checkpoint Combined With Therapeutic Vaccination Restore the Function of Tissue-Resident Anti-viral CD8+ T Cells and Protect Against Recurrent Ocular Herpes Simplex Infection and Disease.

Authors:  Soumyabrata Roy; Pierre-Grégoire Coulon; Ruchi Srivastava; Hawa Vahed; Grace J Kim; Sager S Walia; Taikun Yamada; Mona A Fouladi; Vincent T Ly; Lbachir BenMohamed
Journal:  Front Immunol       Date:  2018-12-17       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.